✦ LIBER ✦

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort

✍ Scribed by Mark L. Wahlqvist; Meei-Shyuan Lee; Chih-Cheng Hsu; Shao-Yuan Chuang; Jiunn-Tay Lee; Hsin-Ni Tsai

Book ID: 116821208
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 351 KB
Volume: 18
Category: Article
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2012.03.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metformin-inclusive sulfonylurea therapy

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort

✍ Mark L. Wahlqvist; Meei-Shyuan Lee; Chih-Cheng Hsu; Shao-Yuan Chuang; Jiunn-Tay 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 351 KB

Objectives Type 2 diabetes (T2DM) may increase the risk of Parkinson's disease (PD). We evaluated the role of oral anti-hyperglycemic agents (OAA) in any diabetes–PD linkage. Methods From the Taiwan National Health Insurance database on 01-01-2000, a representative cohort of 800,000 was obtained be

Dipeptidyl peptidase-4 inhibitors in typ

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study

✍ Kim, S. C.; Schneeweiss, S.; Glynn, R. J.; Doherty, M.; Goldfine, A. B.; Solomon 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 941 KB